Drug Discovery
Phillips-Medisize Increases Global Manufacturing Capacity
Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers in Poland,&n...
October 20, 2021 | News
MSN Labs Launches Empagliflozin tablets at an affordable price for Diabetes Management in India
‘EMPAONE’ is intended to provide diabetes patients in need across India with an affordable and accessible therapeutic option. India being the d...
October 19, 2021 | News
Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection
The BiCNU® brand and generic market had U.S. sales of approximately $19.4 million MAT for the most recent twelve months ending in August 2021 a...
October 18, 2021 | News
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment pro...
October 14, 2021 | News
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat&re...
October 13, 2021 | News
Luciole ,Cyclica to Accelerate Discovery of Novel Medicine
"Luciole aims to be the premier mitochondrial repair company by applying state-of-theart technology and an efficient, virtual company approach to developin...
October 07, 2021 | News
South Korea Advances Treatment of Polymyositis
Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...
September 28, 2021 | News
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002
Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...
September 27, 2021 | News
Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan
Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...
September 23, 2021 | News
Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer
ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...
September 23, 2021 | News
Happiness Biotech Announced The Launch of Its Lucidum Tablets
"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...
September 13, 2021 | News
Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech
Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharm...
September 09, 2021 | News
Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate
With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of slee...
September 08, 2021 | News
GeneQuantum ,BrighGene to develop antibody immune agonist conjugates
GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...
September 07, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
